Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 242

1.

The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia.

Linscott RJ, Morton SE; GROUP (Genetic Risk and Outcome of Psychosis) Investigators.

Schizophr Bull. 2017 Oct 4. doi: 10.1093/schbul/sbx143. [Epub ahead of print]

PMID:
29036385
2.

Changing the obesogenic environment to improve cardiometabolic health in residential patients with a severe mental illness: cluster randomised controlled trial.

Looijmans A, Stiekema APM, Bruggeman R, van der Meer L, Stolk RP, Schoevers RA, Jörg F, Corpeleijn E.

Br J Psychiatry. 2017 Nov;211(5):296-303. doi: 10.1192/bjp.bp.117.199315. Epub 2017 Oct 5.

PMID:
28982656
3.

The relation of vitamin D, metabolic risk and negative symptom severity in people with psychotic disorders.

Bruins J, Jörg F, van den Heuvel ER, Bartels-Velthuis AA, Corpeleijn E, Muskiet FAJ, Pijnenborg GHM, Bruggeman R.

Schizophr Res. 2017 Sep 16. pii: S0920-9964(17)30536-4. doi: 10.1016/j.schres.2017.08.059. [Epub ahead of print] No abstract available.

PMID:
28927862
4.

An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibility.

Pos K, de Wit IE, van Dijk FA, Bartels-Velthuis AA, Bruggeman R, Meijer CJ, de Haan L; for Group; Genetic Risk and Outcome of Psychosis investigators, Alizadeh BZ, Bartels-Velthuis AA, Van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NE, van Os J, van Winkel R.

Psychiatry Res. 2017 Dec;258:234-238. doi: 10.1016/j.psychres.2017.08.017. Epub 2017 Aug 18.

PMID:
28851542
5.

A state-independent network of depressive, negative and positive symptoms in male patients with schizophrenia spectrum disorders.

van Rooijen G, Isvoranu AM, Kruijt OH, van Borkulo CD, Meijer CJ, Wigman JTW, Ruhé HG, de Haan L; GROUP investigators.

Schizophr Res. 2017 Aug 22. pii: S0920-9964(17)30446-2. doi: 10.1016/j.schres.2017.07.035. [Epub ahead of print]

PMID:
28844638
6.

Familial liability to psychosis is a risk factor for multimorbidity in people with psychotic disorders and their unaffected siblings.

Islam MA, Khan MFH, Quee PJ, Snieder H, van den Heuvel ER, Bruggeman R, Alizadeh BZ; GROUP Investigators.

Eur Psychiatry. 2017 Sep;45:81-89. doi: 10.1016/j.eurpsy.2017.05.001. Epub 2017 Jun 1.

PMID:
28750277
7.

Long-term course of negative symptom subdomains and relationship with outcome in patients with a psychotic disorder.

Stiekema APM, Islam MA, Liemburg EJ, Castelein S, van den Heuvel ER, van Weeghel J, Aleman A, Bruggeman R, van der Meer L; GROUP-investigators.

Schizophr Res. 2017 Jun 22. pii: S0920-9964(17)30363-8. doi: 10.1016/j.schres.2017.06.024. [Epub ahead of print]

PMID:
28648915
8.

Effects of low frequency rTMS treatment on brain networks for inner speech in patients with schizophrenia and auditory verbal hallucinations.

Bais L, Liemburg E, Vercammen A, Bruggeman R, Knegtering H, Aleman A.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:105-113. doi: 10.1016/j.pnpbp.2017.04.017. Epub 2017 Apr 22.

PMID:
28442422
9.

The role of cognitive functioning in the relationship between childhood trauma and a mixed phenotype of affective-anxious-psychotic symptoms in psychotic disorders.

Mansueto G, van Nierop M, Schruers K; GROUP Investigators, Alizadeh BZ, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, de Haan L, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, van Haren NEM, van Os J, van Winkel R.

Schizophr Res. 2017 Apr 13. pii: S0920-9964(17)30190-1. doi: 10.1016/j.schres.2017.04.003. [Epub ahead of print]

PMID:
28416093
10.

Persistent Low Rates of Treatment of Metabolic Risk Factors in People With Psychotic Disorders: A PHAMOUS Study.

Bruins J, Pijnenborg GHM, van den Heuvel ER, Visser E, Corpeleijn E, Bartels-Velthuis AA, Bruggeman R, Jörg F.

J Clin Psychiatry. 2017 Sep/Oct;78(8):1117-1125. doi: 10.4088/JCP.16m10831.

PMID:
28406264
12.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.

McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH; Project MinE GWAS Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium.

Nat Commun. 2017 Mar 21;8:14774. doi: 10.1038/ncomms14774.

13.

Obsessive-compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings.

Schirmbeck F, Swets M, Meijer CJ, Zink M, de Haan L; GROUP investigators.

Eur Arch Psychiatry Clin Neurosci. 2016 Dec 17. [Epub ahead of print]

PMID:
27988852
14.

Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.

Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, Antaki D, Shetty A, Holmans PA, Pinto D, Gujral M, Brandler WM, Malhotra D, Wang Z, Fajarado KVF, Maile MS, Ripke S, Agartz I, Albus M, Alexander M, Amin F, Atkins J, Bacanu SA, Belliveau RA Jr, Bergen SE, Bertalan M, Bevilacqua E, Bigdeli TB, Black DW, Bruggeman R, Buccola NG, Buckner RL, Bulik-Sullivan B, Byerley W, Cahn W, Cai G, Cairns MJ, Campion D, Cantor RM, Carr VJ, Carrera N, Catts SV, Chambert KD, Cheng W, Cloninger CR, Cohen D, Cormican P, Craddock N, Crespo-Facorro B, Crowley JJ, Curtis D, Davidson M, Davis KL, Degenhardt F, Del Favero J, DeLisi LE, Dikeos D, Dinan T, Djurovic S, Donohoe G, Drapeau E, Duan J, Dudbridge F, Eichhammer P, Eriksson J, Escott-Price V, Essioux L, Fanous AH, Farh KH, Farrell MS, Frank J, Franke L, Freedman R, Freimer NB, Friedman JI, Forstner AJ, Fromer M, Genovese G, Georgieva L, Gershon ES, Giegling I, Giusti-Rodríguez P, Godard S, Goldstein JI, Gratten J, de Haan L, Hamshere ML, Hansen M, Hansen T, Haroutunian V, Hartmann AM, Henskens FA, Herms S, Hirschhorn JN, Hoffmann P, Hofman A, Huang H, Ikeda M, Joa I, Kähler AK, Kahn RS, Kalaydjieva L, Karjalainen J, Kavanagh D, Keller MC, Kelly BJ, Kennedy JL, Kim Y, Knowles JA, Konte B, Laurent C, Lee P, Lee SH, Legge SE, Lerer B, Levy DL, Liang KY, Lieberman J, Lönnqvist J, Loughland CM, Magnusson PKE, Maher BS, Maier W, Mallet J, Mattheisen M, Mattingsdal M, McCarley RW, McDonald C, McIntosh AM, Meier S, Meijer CJ, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mokrab Y, Morris DW, Müller-Myhsok B, Murphy KC, Murray RM, Myin-Germeys I, Nenadic I, Nertney DA, Nestadt G, Nicodemus KK, Nisenbaum L, Nordin A, O'Callaghan E, O'Dushlaine C, Oh SY, Olincy A, Olsen L, O'Neill FA, Van Os J, Pantelis C, Papadimitriou GN, Parkhomenko E, Pato MT, Paunio T; Psychosis Endophenotypes International Consortium, Perkins DO, Pers TH, Pietiläinen O, Pimm J, Pocklington AJ, Powell J, Price A, Pulver AE, Purcell SM, Quested D, Rasmussen HB, Reichenberg A, Reimers MA, Richards AL, Roffman JL, Roussos P, Ruderfer DM, Salomaa V, Sanders AR, Savitz A, Schall U, Schulze TG, Schwab SG, Scolnick EM, Scott RJ, Seidman LJ, Shi J, Silverman JM, Smoller JW, Söderman E, Spencer CCA, Stahl EA, Strengman E, Strohmaier J, Stroup TS, Suvisaari J, Svrakic DM, Szatkiewicz JP, Thirumalai S, Tooney PA, Veijola J, Visscher PM, Waddington J, Walsh D, Webb BT, Weiser M, Wildenauer DB, Williams NM, Williams S, Witt SH, Wolen AR, Wormley BK, Wray NR, Wu JQ, Zai CC, Adolfsson R, Andreassen OA, Blackwood DHR, Bramon E, Buxbaum JD, Cichon S, Collier DA, Corvin A, Daly MJ, Darvasi A, Domenici E, Esko T, Gejman PV, Gill M, Gurling H, Hultman CM, Iwata N, Jablensky AV, Jönsson EG, Kendler KS, Kirov G, Knight J, Levinson DF, Li QS, McCarroll SA, McQuillin A, Moran JL, Mowry BJ, Nöthen MM, Ophoff RA, Owen MJ, Palotie A, Pato CN, Petryshen TL, Posthuma D, Rietschel M, Riley BP, Rujescu D, Sklar P, St Clair D, Walters JTR, Werge T, Sullivan PF, O'Donovan MC, Scherer SW, Neale BM, Sebat J; CNV and Schizophrenia Working Groups of the Psychiatric Genomics Consortium.

Nat Genet. 2017 Jan;49(1):27-35. doi: 10.1038/ng.3725. Epub 2016 Nov 21.

PMID:
27869829
15.

[A study of cost-effectiveness of treating serious mental illness: challenges and solutions].

Lokkerbol J, Nuijen J, Evers S, Knegtering H, Delespaul P, Kroon H, Bruggeman R.

Tijdschr Psychiatr. 2016;58(10):700-705. Dutch.

16.

Reduced specialized processing in psychotic disorder: a graph theoretical analysis of cerebral functional connectivity.

Peeters SC, Gronenschild EH, van Amelsvoort T, van Os J, Marcelis M; Genetic Risk and Outcome of Psychosis (G.R.O.U.P.), Kahn R, Wiersma D, Bruggeman R, Cahn W, de Haan L, Meijer C, Myin-Germeys I.

Brain Behav. 2016 Jun 29;6(9):e00508. eCollection 2016 Sep.

17.

Cannabis and a lower BMI in psychosis: What is the role of AKT1?

Liemburg EJ, Bruins J, van Beveren N, Islam MA, Alizadeh BZ; GROUP investigators.

Schizophr Res. 2016 Oct;176(2-3):95-99. doi: 10.1016/j.schres.2016.08.014. Epub 2016 Aug 21.

PMID:
27554198
18.

Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer.

Yang X, Liu Y, Mani H, Olson J, Clawson G, Caruso C, Bruggeman R, Varlotto JM, Zander DS, Rassaei N.

Pathol Oncol Res. 2017 Jan;23(1):73-77. doi: 10.1007/s12253-016-0086-1. Epub 2016 Jul 13.

PMID:
27411924
19.

Prevalence and classification of hallucinations in multiple sensory modalities in schizophrenia spectrum disorders.

Lim A, Hoek HW, Deen ML, Blom JD; GROUP Investigators.

Schizophr Res. 2016 Oct;176(2-3):493-499. doi: 10.1016/j.schres.2016.06.010. Epub 2016 Jun 25.

20.

Treatment of negative symptoms: Where do we stand, and where do we go?

Aleman A, Lincoln TM, Bruggeman R, Melle I, Arends J, Arango C, Knegtering H.

Schizophr Res. 2017 Aug;186:55-62. doi: 10.1016/j.schres.2016.05.015. Epub 2016 Jun 9. Review.

PMID:
27293137

Supplemental Content

Loading ...
Support Center